Garlic in Hyperlipidemia Caused by HAART
HIV Infections, Hypercholesterolemia, Hypertriglyceridemia
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring complementary therapies, garlic, Allium sativum, metabolic diseases, HAART, Protease inhibitors
Eligibility Criteria
Inclusion Criteria: HIV-1 seropositive confirmed by medical history On stable HAART for at least 6 months before study entry without the likelihood of HAART therapy changes in the following 6 months due to viral rebound or adverse events CD4+ lymphocyte number > 100 cells/mm3 measured within 60 days before study entry HIV-1 viral load < 2000 RNA copies/ml Cholesterol > 200 mg/dL Triglycerides > 250 mg/dL < 1000 mg/dL Willing and able to avoid raw or dry garlic, onion, leeks and shallots as well as supplements containing garlic during the 16 weeks of the trial Willing and able to provide inform consent Willing and able to understand and follow protocol for the duration of the study Willing and able to maintain a consistent lifestyle routine, eg. diet, exercise, medications, dietary supplements and sleep schedule for the duration of the study Willing and able to understand and follow the Step 1 guidelines from the National Cholesterol Education Program (NCEP) for the duration of the study Willing to remain adherent to the current HAART regimen
Sites / Locations
- Bastyr University Center for Natural Health
- University of Washington Harborview Medical Center